The gene product of CBFB-MYH11

Leukemia

Volumn 10, Issue 9, 1996, Pages 1479-1485

  Claxton, D ^a   Xie, Q S ^b   Patel, S ^b   Deisseroth, A B ^b   Kornblau, S ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b NONE

Author keywords

CBF; Leukemia; Leukemogenesis

Indexed keywords

ANTISERUM; GENE PRODUCT; PROTEIN SUBUNIT;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CHROMOSOME 16; CHROMOSOME INVERSION; GENE FUSION; GENETIC TRANSCRIPTION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

EID: 0029740515     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. LeBeau M, Larson R, Bitter M, Vardiman J, Golomb H, Rowley J. Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. New Engl J Med 1983; 309: 630-636.
2. Marlton P, Keating M, Kantarjian H, Pierce S, O'Brien S, Freireich EJ, Estey E. Cytogenetic and clinical correlates in AML patients with abnormalities of chromsome 16. Leukemia 1995; 9: 965-971.
3. Bloomfield CD, Lawrence D, Arthur DC, Berg DT, Schiffer CA, Mayer Rj. Curative impact of intensification with high dose cytarabine in acute myelogenous leukemia varies by cytogenetic sub-group. Blood 1994; 84: (Suppl): 111a.
4. Liu P, Claxton DF, Marlton P, Hajra A, Siciliano J, Freedman M, Chandrasekharappa SC, Yanagisawa K, Stallings RL, Collins FS et al. Identification of yeast artificial chromosomes containing the inversion 16 p-arm breakpoint associated with acute myelomonocytic leukemia. Blood 1993; 82: 16-721.
5. Liu P, Tarlé SA, Hajra A, Claxton DF, Marlton P, Freedman M, Siciliano MJ, Collins FS. Fusion between transcription factor CBFβ/PEBP2β and a myosin heavy chain in acute myeloid leuke-mia. Science 1993; 261: 1041-1044.
6. Dauwerse JC, Wessels JW, Giles RH, Weigant J, Van der Reijden BA, Fugazza G, Jumelet EA, Smit E, Baas F, Raap AK et al. Cloning the breakpoint cluster region of the inv(16) in acute nonlymphocytic leukemia M4 Eo. Hum Mol Genet 1993; 2: 1527-1534.
7. Erickson P, Gao J, Chang K-S, Look T, Whisenant E, Raimondi S, Lasher R, Trujillo J, Rowley J, Drabkin H. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood 1992; 80: 1825-1831.
8. Nucifora G, Birn DJ, Espinosa R III, Erickson P, LeBeau MM, Roulston D, McKeithan TW, Drabkin H, Rowley JD. Involvement of the AML1 gene in the t(3;21) in therapy-related leukemia and in chronic myeloid leukemia in blast crisis. Blood 1993; 81: 2728-2734.
9. Claxton DF, Liu P, Hsu HB, Marlton P, Hester J, Collins F, Deisseroth AB, Rowley JD, Siciliano MJ. Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelogenous leukemia. Blood 1994; 83: 1750-1756.
10. Poirel H, Radford-Weiss I, Rack K, Troussard X, Veil A, Valensi F, Picard F, Guesnu M, Leboeuf D, Melle J et al. Detection of the chromosome 16 CBFβ-MYH11 fusion transcript in myelomonocytic leukemias. Blood 1995; 85: 1313-1322.
11. Novak M, Laczika K, Mitterbauer M, Purtscher B, Scheidel-Petrovic A, Lechner K, Jaeger U. Novel CBFβ-MYH11 fusion transcripts and alternative splicing in acute myeloid leukemia with inversion of chromosome 16. Blood 1995; 86: 2449-2450.
12. Shurtleff SA, Meyers S, Hiebert SW, Raimondi SC, Head DR, Willman CL, Wolman S, Slovak ML, Caroll AJ, Behm F et al. Heterogeneity in CBFβ/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p1 3;q22) in actue myelogenous leukemia. Blood 1995; 85: 3695-3703.
13. Liu P, Seidel N, Bodine D, Speck N, Tarlé S, Collins FS. Acute myeloid leukemia with inv(16) produces a chimeric transcription factor with a myosin heavy chain tail. Cold Spring Harbor Symp Quant Biol 1994; 59: 547-554.
14. Van der Reijden BA, Dauwerse JG, Wessels JW, Beverstock GC, Hagemeijer A, van Ommen GJB, Breuning MH. A gene for a myosin peptide is disrupted by the inv(16)(p13q22) in acute nonlymphocytic leukemia M4Eo. Blood 1993; 82: 2948-2952.
15. Wang S, Wang Q, Crute BE, Melnikova IN, Keller SR, Speck NA. Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding-factor. Mol Cell Biol 1993; 13: 3324-3339.
16. Ogawa E, Inuzuka M, Maruyama M, Satake M, Naito-Fujimoto M, Ito Y, Shigesada K. Molecular cloning and characterization of PEBp2b, the heterodimeric partner of a novel drosophilia runt related DNA binding protein PEBP2a. Virology 1993; 194: 314-331.
17. Aikawa M, Sivam P, Kuro-o M, Kimura K, Nakahara K, Takewaki S, Ueda M, Yamaguchi H, Yazaki Y, Periasarny M. Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis. Circulation Res 1993; 73: 1000-1012.
18. Nagai R, Kuro-o M, Babij P, Periasarny M. Identification of two types of smooth muscle myosin heavy chain isoforms by cDNA cloning and immunoblot analysis. J Biol Chem 1989; 364: 9734-9737.
19. Lu J, Maruyama M, Satake M, Bae S-C, Ogawa E, Kagoshima H, Shigesada K, Ito Y. Subcellular localization of the α and β subunits of the acute myeloid leukemia-linked transcription factor PEBP2/CBF. Mol Cell Biol 1995; 15: 1651-1661.
20. Hajra A, Liu PP, Wang Q, Kelley CA, Stacy T, Adelstein RS, Speck NA, Collins FS. The leukemic core binding factor β-smooth muscle myosin heavy chain (CBFβ-SMMHC) chimeric protein requires both CBFβ and myosin heavy chain domains for transformation of NIH 3T3 cells. Proc Natl Acad Sci USA 1995; 92: 1926-1930.
21. Matsuoka R, Yoshida M, Furutani Y, Imamura S, Kanda N, Yanagisawa M, Masaki T, Takao A. Human smooth muscle myosin heavy chain gene mapped to chromosomal region 16q12. Am J Med Genet 1993; 46: 61-67.
22. Kornblau SM, Xu H-J, Del Giglio A, Hu S-X, Zhang W, Calvert L, Beran M, Estey E, Andreeff M, Trujillo J et al. Clinical implications of decreased retinoblastoma protein expression in acute myelogenous leukemia. Cancer Res 1992; 52: 4587-4590.
23. Malter JS. Identification of an AUUUA-specific massenger RNA binding protein. Science 1989; 246: 664-666.
24. Brauerman G. mRNA decay: finding the right targets. Cell 1989; 57: 9-10.
25. Zent CS, Mathieu C, Claxton DF, Zhang D-E, Tenen DC, Rowley JD, Nucifora G. The chimeric genes AML1/MDS1 and AML1/EAP inhibit AMLIB activation at the CSF1R promoter, but only AML1/MDS1 has tumor-promotor properties. Proc Natl Acad Sci USA 1996; 93: 1044-1048.